N-fragment of edema factor as a candidate antigen for immunization against anthrax

Vaccine

Volumn 24, Issue 5, 2006, Pages 662-670

  Zeng, Mingtao ^a   Xu, Qingfu ^a   Hesek, Eric D ^a   Pichichero, Michael E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Anthrax vaccine; Edema factor; Protective immunity; Replication incompetent adenovirus

Indexed keywords

ADENOVIRUS VECTOR; AMINO ACID; ANTHRAX TOXIN; ANTHRAX VACCINE; ANTIBODY; EDEMA FACTOR ANTIBODY; EDEMA TOXIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; N TERMINAL FRAGMENT OF BACULLUS ANTHRACIS EDEMA FACTOR; TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; CELL LINE; CHO CELL; CONTROLLED STUDY; CROSS REACTION; DNA SEQUENCE; FEMALE; GENE DELETION; GENETIC CODE; IMMUNOGLOBULIN PRODUCTION; LD 50; LETHAL GENE; MACROPHAGE; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TOXIN ANALYSIS; VIRUS GENE;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CROSS REACTIONS; CYCLIC AMP; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; SPORES, BACTERIAL; VACCINES, SYNTHETIC;

EID: 29544437444     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.056     Document Type: Article

References (62)

1. M. Mock, A. Fouet, and Anthrax Annu Rev Microbiol 55 2001 647 671
2. P.R. Pittman, P.H. Gibbs, T.L. Cannon, and A.M. Friedlander Anthrax vaccine: short-term safety experience in humans Vaccine 20 5-6 2001 972 978
3. T.C. Dixon, M. Meselson, J. Guillemin, P.C. Hanna, and Anthrax N Engl J Med 341 11 1999 815 826
4. S.L. Welkos Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis Microb Pathog 10 3 1991 183 198
5. J.W. Ezzell, and S.L. Welkos The capsule of bacillus anthracis, a review J Appl Microbiol 87 2 1999 250
6. F. Brossier, and M. Mock Toxins of Bacillus anthracis Toxicon 39 11 2001 1747 1755
7. K.A. Bradley, and J.A. Young Anthrax toxin receptor proteins Biochem Pharmacol 65 3 2003 309 314
8. E. Santelli, L.A. Bankston, S.H. Leppla, and R.C. Liddington Crystal structure of a complex between anthrax toxin and its host cell receptor Nature 4 2004 4
9. K.A. Bradley, J. Mogridge, M. Mourez, R.J. Collier, and J.A. Young Identification of the cellular receptor for anthrax toxin Nature 414 6860 2001 225 229
10. H.M. Scobie, G.J. Rainey, K.A. Bradley, and J.A. Young Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor Proc Natl Acad Sci USA 100 9 2003 5170 5174
11. Y. Singh, K.R. Klimpel, S. Goel, P.K. Swain, and S.H. Leppla Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells Infect Immun 67 4 1999 1853 1859
12. Y. Singh, B.E. Ivins, and S.H. Leppla Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis Infect Immun 66 7 1998 3447 3448
13. N. Kushner, D. Zhang, N. Touzjian, M. Essex, J. Lieberman, and Y. Lu A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen Proc Natl Acad Sci USA 100 11 2003 6652 6657
14. S.H. Leppla Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Proc Natl Acad Sci USA 79 10 1982 3162 3166
15. S.H. Leppla Anthrax toxin K. Aktories I. Just Bacterial Protein Toxins 145 2000 Springer-Verlag Berlin, Heidelberg, Berlin 445 472
16. B.G. Mahlandt, F. Klein, R.E. Lincoln, B.W. Haines, W.I. Jones Jr., and R.H. Friedman Immunologic studies of anthrax IV. Evaluation of the immunogenicity of three components of anthrax toxin J Immunol 96 4 1966 727 733
17. S. Welkos, S. Little, A. Friedlander, D. Fritz, and P. Fellows The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores Microbiology 147 Part 6 2001 1677 1685
18. Anthrax Vaccine Adsorbed (BioThrax) Product insert. BioPort Corporation, Lansing, Michigan; 2002.
19. A.M. Friedlander, P.R. Pittman, and G.W. Parker Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax JAMA 282 22 1999 2104 2106
20. B.E. Ivins, S.L. Welkos, S.F. Little, M.H. Crumrine, and G.O. Nelson Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants Infect Immun 60 2 1992 662 668
21. G.R. Matyas, A.M. Friedlander, G.M. Glenn, S. Little, J. Yu, and C.R. Alving Needle-free skin patch vaccination method for anthrax Infect Immun 72 2 2004 1181 1183
22. R.T. Kenney, J. Yu, M. Guebre-Xabier, S.A. Frech, A. Lambert, and B.A. Heller Induction of protective immunity against lethal anthrax challenge with a patch J Infect Dis 190 4 2004 774 782 Epub 2004 Jul 2013
23. G.E. Rhie, M.H. Roehrl, M. Mourez, R.J. Collier, J.J. Mekalanos, and J.Y. Wang A dually active anthrax vaccine that confers protection against both bacilli and toxins Proc Natl Acad Sci USA 100 19 2003 10925 10930
24. D.J. Chabot, A. Scorpio, S.A. Tobery, S.F. Little, S.L. Norris, and A.M. Friedlander Anthrax capsule vaccine protects against experimental infection Vaccine 23 1 2004 43 47
25. H.C. Flick-Smith, N.J. Walker, P. Gibson, H. Bullifent, S. Hayward, and J. Miller A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection Infect Immun 70 3 2002 1653 1656
26. M.L. Gu, S.H. Leppla, and D.M. Klinman Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen Vaccine 17 4 1999 340 344
27. J. Riemenschneider, A. Garrison, J. Geisbert, P. Jahrling, M. Hevey, and D. Negley Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus Vaccine 21 25-26 2003 4071 4080
28. Y. Tan, N.R. Hackett, J.L. Boyer, and R.G. Crystal Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen Hum Gene Ther 14 17 2003 1673 1682
29. H.S. Garmory, R.W. Titball, K.F. Griffin, U. Hahn, R. Bohm, and W. Beyer Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge Infect Immun 71 7 2003 3831 3836
30. N.M. Coulson, M. Fulop, and R.W. Titball Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge Vaccine 12 15 1994 1395 1401
31. B.E. Ivins, and S.L. Welkos Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis Infect Immun 54 2 1986 537 542
32. L.C. Iacono-Connors, S.L. Welkos, B.E. Ivins, and J.M. Dalrymple Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals Infect Immun 59 6 1991 1961 1965
33. J.S. Lee, A.G. Hadjipanayis, and S.L. Welkos Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge Infect Immun 71 3 2003 1491 1496
34. S.F. Little, J.M. Novak, J.R. Lowe, S.H. Leppla, Y. Singh, and K.R. Klimpel Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies Microbiology 142 Part 3 1996 707 715
35. B.M. Price, A.L. Liner, S. Park, S.H. Leppla, A. Mateczun, and D.R. Galloway Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein Infect Immun 69 7 2001 4509 4515
36. D. Galloway, A. Liner, J. Legutki, A. Mateczun, R. Barnewall, and J. Estep Genetic immunization against anthrax Vaccine 22 13-14 2004 1604 1608
37. J.W. Ezzell Jr., and T.G. Abshire Immunological analysis of cell-associated antigens of Bacillus anthracis Infect Immun 56 2 1988 349 356
38. P.C. Turnbull, M.G. Broster, J.A. Carman, R.J. Manchee, and J. Melling Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity Infect Immun 52 2 1986 356 363
39. P.C. Turnbull, S.H. Leppla, M.G. Broster, C.P. Quinn, and J. Melling Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity Med Microbiol Immunol (Berl) 177 5 1988 293 303
40. S.L. Welkos, and A.M. Friedlander Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice Microb Pathog 5 2 1988 127 139
41. S. Reuveny, M.D. White, Y.Y. Adar, Y. Kafri, Z. Altboum, and Y. Gozes Search for correlates of protective immunity conferred by anthrax vaccine Infect Immun 69 5 2001 2888 2893
42. C. Pezard, M. Weber, J.C. Sirard, P. Berche, and M. Mock Protective immunity induced by Bacillus anthracis toxin-deficient strains Infect Immun 63 4 1995 1369 1372
43. S. Cohen, I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, and T. Bino Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax Infect Immun 68 8 2000 4549 4558
44. N. Arora, and S.H. Leppla Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides J Biol Chem 268 5 1993 3334 3341
45. N. Arora Site directed mutagenesis of histidine residues in anthrax toxin lethal factor binding domain reduces toxicity Mol Cell Biochem 177 1-2 1997 7 14
46. P. Gupta, A. Singh, V. Chauhan, and R. Bhatnagar Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis Biochem Biophys Res Commun 280 1 2001 158 163
47. A.D. Pannifer, T.Y. Wong, R. Schwarzenbacher, M. Renatus, C. Petosa, and J. Bienkowska Crystal structure of the anthrax lethal factor Nature 414 6860 2001 229 233
48. S.F. Little, S.H. Leppla, J.W. Burnett, and A.M. Friedlander Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies Biochem Biophys Res Commun 199 2 1994 676 682
49. S.A. Lukashok, and M.S. Horwitz New perspectives in adenoviruses Curr Clin Topics Infect Dis 18 1998 286 305
50. Z. Shi, M. Zeng, G. Yang, F. Siegel, L.J. Cain, and K.R. van Kampen Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines J Virol 75 23 2001 11474 11482
51. M.D. Lubeck, R. Natuk, M. Myagkikh, N. Kalyan, K. Aldrich, and F. Sinangil Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization Nat Med 3 6 1997 651 658
52. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 2002 331 335
53. D.L. Robertson, M.T. Tippetts, and S.H. Leppla Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase Gene 73 2 1988 363 371
54. S.L. Welkos, T.J. Keener, and P.H. Gibbs Differences in susceptibility of inbred mice to Bacillus anthracis Infect Immun 51 3 1986 795 800
55. J.F. Zmuda, L. Zhang, T. Richards, Q. Pham, D. Zukauskas, and J.L. Pierre Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen J Immunol Methods 298 1-2 2005 47 60
56. S.F. Little, S.H. Leppla, A.M. Friedlander, B.E. Ivins, S.L. Welkos, and G.B. Knudson Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin Infect Immun 58 6 1990 1606 1613
57. P.F. Ertl, and L.L. Thomsen Technical issues in construction of nucleic acid vaccines Methods 31 3 2003 199 206
58. G. Hermanson, V. Whitlow, S. Parker, K. Tonsky, D. Rusalov, and M. Ferrari A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores Proc Natl Acad Sci USA 101 37 2004 13601 13606 Epub 2004 Sep 13601
59. R. Vogels, D. Zuijdgeest, R. van Rijnsoever, E. Hartkroon, I. Damen, and M.P. de Bethune Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity J Virol 77 15 2003 8263 8271
60. X. Nan, B. Peng, T.W. Hahn, E. Richardson, A. Lizonova, and I. Kovesdi Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus Gene Ther 10 4 2003 326 336
61. C. Hofmann, P. Loser, G. Cichon, W. Arnold, G.W. Both, and M. Strauss Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo J Virol 73 8 1999 6930 6936
62. S.F. Farina, G.P. Gao, Z.Q. Xiang, J.J. Rux, R.M. Burnett, and M.R. Alvira Replication-defective vector based on a chimpanzee adenovirus J Virol 75 23 2001 11603 11613